The IARC Perspective on Cervical Cancer Screening
Véronique BouvardAmerican Cancer Society (R. Smith), Emory University (M.H.C.), and Centers for Disease Control and Prevention (M. Saraiya), Atlanta, GA; Amsterdam University Medical Centers, Amsterdam, the Netherlands (J. Berkhof); Azienda Unità Sanitaria Locale, IRCCS Reggio Emilia, Reggio Emilia, Italy (P.G.-R.); Casablanca Cancer Registry, Casablanca, Morocco (K.B.); Center for the Study of the State and Society (S.A.), and National Scientific and Technical Research Council (S.A.), Buenos Aires, Argentina; Chinese Academy of Medical Sciences, Beijing, China (F.Z.); Hospital Clínic de Barcelona, Barcelona, Spain (M.d.P.); Hospital Universitario San Ignacio, Bogota, Colombia (R.M.); International Agency for Research on Cancer, Lyon (V.B., W.P., B.I.I.R., I.M.-M., B.L.-S.); Karolinska Institutet, Stockholm, Sweden (M.E.); McGill University, Montreal, Quebec, Canada (E.L.F.); National Cancer Institute, Bangkok, Thailand (S.S.); National Cancer Institute, Rockville, MD (N.W., M. Schiffman); National Public Health Agency, Saint-Maurice (F.F.H.), France; PATH, Seattle, WA (S.d.S.); Public Health England and Screening, London, United Kingdom (A.M.); Research Triangle Institute International, New Delhi, India (R. Sankaranarayanan); Teikyo University (C.H.), and National Cancer Center (C.H.), Tokyo, Japan; The Daffodil Centre, a joint venture between the Cancer Council NSW and the University of Sydney, King's Cross, New South Wales, Australia (K.C.); University of Edinburgh, Edinburgh, United Kingdom (C.S.H.); University of Toronto, Toronto, Ontario, Canada (R.K.); University of Zimbabwe College of Health Sciences, Harare, Zimbabwe (Z.M.C.); VCS Foundation, Melbourne, Victoria, Australia (J. Brotherton); and Sciensano, Brussels, Belgium (M.A.)Nicolas WentzensenAmerican Cancer Society (R. Smith), Emory University (M.H.C.), and Centers for Disease Control and Prevention (M. Saraiya), Atlanta, GA; Amsterdam University Medical Centers, Amsterdam, the Netherlands (J. Berkhof); Azienda Unità Sanitaria Locale, IRCCS Reggio Emilia, Reggio Emilia, Italy (P.G.-R.); Casablanca Cancer Registry, Casablanca, Morocco (K.B.); Center for the Study of the State and Society (S.A.), and National Scientific and Technical Research Council (S.A.), Buenos Aires, Argentina; Chinese Academy of Medical Sciences, Beijing, China (F.Z.); Hospital Clínic de Barcelona, Barcelona, Spain (M.d.P.); Hospital Universitario San Ignacio, Bogota, Colombia (R.M.); International Agency for Research on Cancer, Lyon (V.B., W.P., B.I.I.R., I.M.-M., B.L.-S.); Karolinska Institutet, Stockholm, Sweden (M.E.); McGill University, Montreal, Quebec, Canada (E.L.F.); National Cancer Institute, Bangkok, Thailand (S.S.); National Cancer Institute, Rockville, MD (N.W., M. Schiffman); National Public Health Agency, Saint-Maurice (F.F.H.), France; PATH, Seattle, WA (S.d.S.); Public Health England and Screening, London, United Kingdom (A.M.); Research Triangle Institute International, New Delhi, India (R. Sankaranarayanan); Teikyo University (C.H.), and National Cancer Center (C.H.), Tokyo, Japan; The Daffodil Centre, a joint venture between the Cancer Council NSW and the University of Sydney, King's Cross, New South Wales, Australia (K.C.); University of Edinburgh, Edinburgh, United Kingdom (C.S.H.); University of Toronto, Toronto, Ontario, Canada (R.K.); University of Zimbabwe College of Health Sciences, Harare, Zimbabwe (Z.M.C.); VCS Foundation, Melbourne, Victoria, Australia (J. Brotherton); and Sciensano, Brussels, Belgium (M.A.)Anne MackieAmerican Cancer Society (R. Smith), Emory University (M.H.C.), and Centers for Disease Control and Prevention (M. Saraiya), Atlanta, GA; Amsterdam University Medical Centers, Amsterdam, the Netherlands (J. Berkhof); Azienda Unità Sanitaria Locale, IRCCS Reggio Emilia, Reggio Emilia, Italy (P.G.-R.); Casablanca Cancer Registry, Casablanca, Morocco (K.B.); Center for the Study of the State and Society (S.A.), and National Scientific and Technical Research Council (S.A.), Buenos Aires, Argentina; Chinese Academy of Medical Sciences, Beijing, China (F.Z.); Hospital Clínic de Barcelona, Barcelona, Spain (M.d.P.); Hospital Universitario San Ignacio, Bogota, Colombia (R.M.); International Agency for Research on Cancer, Lyon (V.B., W.P., B.I.I.R., I.M.-M., B.L.-S.); Karolinska Institutet, Stockholm, Sweden (M.E.); McGill University, Montreal, Quebec, Canada (E.L.F.); National Cancer Institute, Bangkok, Thailand (S.S.); National Cancer Institute, Rockville, MD (N.W., M. Schiffman); National Public Health Agency, Saint-Maurice (F.F.H.), France; PATH, Seattle, WA (S.d.S.); Public Health England and Screening, London, United Kingdom (A.M.); Research Triangle Institute International, New Delhi, India (R. Sankaranarayanan); Teikyo University (C.H.), and National Cancer Center (C.H.), Tokyo, Japan; The Daffodil Centre, a joint venture between the Cancer Council NSW and the University of Sydney, King's Cross, New South Wales, Australia (K.C.); University of Edinburgh, Edinburgh, United Kingdom (C.S.H.); University of Toronto, Toronto, Ontario, Canada (R.K.); University of Zimbabwe College of Health Sciences, Harare, Zimbabwe (Z.M.C.); VCS Foundation, Melbourne, Victoria, Australia (J. Brotherton); and Sciensano, Brussels, Belgium (M.A.)Johannes BerkhofAmerican Cancer Society (R. Smith), Emory University (M.H.C.), and Centers for Disease Control and Prevention (M. Saraiya), Atlanta, GA; Amsterdam University Medical Centers, Amsterdam, the Netherlands (J. Berkhof); Azienda Unità Sanitaria Locale, IRCCS Reggio Emilia, Reggio Emilia, Italy (P.G.-R.); Casablanca Cancer Registry, Casablanca, Morocco (K.B.); Center for the Study of the State and Society (S.A.), and National Scientific and Technical Research Council (S.A.), Buenos Aires, Argentina; Chinese Academy of Medical Sciences, Beijing, China (F.Z.); Hospital Clínic de Barcelona, Barcelona, Spain (M.d.P.); Hospital Universitario San Ignacio, Bogota, Colombia (R.M.); International Agency for Research on Cancer, Lyon (V.B., W.P., B.I.I.R., I.M.-M., B.L.-S.); Karolinska Institutet, Stockholm, Sweden (M.E.); McGill University, Montreal, Quebec, Canada (E.L.F.); National Cancer Institute, Bangkok, Thailand (S.S.); National Cancer Institute, Rockville, MD (N.W., M. Schiffman); National Public Health Agency, Saint-Maurice (F.F.H.), France; PATH, Seattle, WA (S.d.S.); Public Health England and Screening, London, United Kingdom (A.M.); Research Triangle Institute International, New Delhi, India (R. Sankaranarayanan); Teikyo University (C.H.), and National Cancer Center (C.H.), Tokyo, Japan; The Daffodil Centre, a joint venture between the Cancer Council NSW and the University of Sydney, King's Cross, New South Wales, Australia (K.C.); University of Edinburgh, Edinburgh, United Kingdom (C.S.H.); University of Toronto, Toronto, Ontario, Canada (R.K.); University of Zimbabwe College of Health Sciences, Harare, Zimbabwe (Z.M.C.); VCS Foundation, Melbourne, Victoria, Australia (J. Brotherton); and Sciensano, Brussels, Belgium (M.A.)Julia BrothertonAmerican Cancer Society (R. Smith), Emory University (M.H.C.), and Centers for Disease Control and Prevention (M. Saraiya), Atlanta, GA; Amsterdam University Medical Centers, Amsterdam, the Netherlands (J. Berkhof); Azienda Unità Sanitaria Locale, IRCCS Reggio Emilia, Reggio Emilia, Italy (P.G.-R.); Casablanca Cancer Registry, Casablanca, Morocco (K.B.); Center for the Study of the State and Society (S.A.), and National Scientific and Technical Research Council (S.A.), Buenos Aires, Argentina; Chinese Academy of Medical Sciences, Beijing, China (F.Z.); Hospital Clínic de Barcelona, Barcelona, Spain (M.d.P.); Hospital Universitario San Ignacio, Bogota, Colombia (R.M.); International Agency for Research on Cancer, Lyon (V.B., W.P., B.I.I.R., I.M.-M., B.L.-S.); Karolinska Institutet, Stockholm, Sweden (M.E.); McGill University, Montreal, Quebec, Canada (E.L.F.); National Cancer Institute, Bangkok, Thailand (S.S.); National Cancer Institute, Rockville, MD (N.W., M. Schiffman); National Public Health Agency, Saint-Maurice (F.F.H.), France; PATH, Seattle, WA (S.d.S.); Public Health England and Screening, London, United Kingdom (A.M.); Research Triangle Institute International, New Delhi, India (R. Sankaranarayanan); Teikyo University (C.H.), and National Cancer Center (C.H.), Tokyo, Japan; The Daffodil Centre, a joint venture between the Cancer Council NSW and the University of Sydney, King's Cross, New South Wales, Australia (K.C.); University of Edinburgh, Edinburgh, United Kingdom (C.S.H.); University of Toronto, Toronto, Ontario, Canada (R.K.); University of Zimbabwe College of Health Sciences, Harare, Zimbabwe (Z.M.C.); VCS Foundation, Melbourne, Victoria, Australia (J. Brotherton); and Sciensano, Brussels, Belgium (M.A.)Paolo Giorgi RossiAmerican Cancer Society (R. Smith), Emory University (M.H.C.), and Centers for Disease Control and Prevention (M. Saraiya), Atlanta, GA; Amsterdam University Medical Centers, Amsterdam, the Netherlands (J. Berkhof); Azienda Unità Sanitaria Locale, IRCCS Reggio Emilia, Reggio Emilia, Italy (P.G.-R.); Casablanca Cancer Registry, Casablanca, Morocco (K.B.); Center for the Study of the State and Society (S.A.), and National Scientific and Technical Research Council (S.A.), Buenos Aires, Argentina; Chinese Academy of Medical Sciences, Beijing, China (F.Z.); Hospital Clínic de Barcelona, Barcelona, Spain (M.d.P.); Hospital Universitario San Ignacio, Bogota, Colombia (R.M.); International Agency for Research on Cancer, Lyon (V.B., W.P., B.I.I.R., I.M.-M., B.L.-S.); Karolinska Institutet, Stockholm, Sweden (M.E.); McGill University, Montreal, Quebec, Canada (E.L.F.); National Cancer Institute, Bangkok, Thailand (S.S.); National Cancer Institute, Rockville, MD (N.W., M. Schiffman); National Public Health Agency, Saint-Maurice (F.F.H.), France; PATH, Seattle, WA (S.d.S.); Public Health England and Screening, London, United Kingdom (A.M.); Research Triangle Institute International, New Delhi, India (R. Sankaranarayanan); Teikyo University (C.H.), and National Cancer Center (C.H.), Tokyo, Japan; The Daffodil Centre, a joint venture between the Cancer Council NSW and the University of Sydney, King's Cross, New South Wales, Australia (K.C.); University of Edinburgh, Edinburgh, United Kingdom (C.S.H.); University of Toronto, Toronto, Ontario, Canada (R.K.); University of Zimbabwe College of Health Sciences, Harare, Zimbabwe (Z.M.C.); VCS Foundation, Melbourne, Victoria, Australia (J. Brotherton); and Sciensano, Brussels, Belgium (M.A.)Rachel KupetsAmerican Cancer Society (R. Smith), Emory University (M.H.C.), and Centers for Disease Control and Prevention (M. Saraiya), Atlanta, GA; Amsterdam University Medical Centers, Amsterdam, the Netherlands (J. Berkhof); Azienda Unità Sanitaria Locale, IRCCS Reggio Emilia, Reggio Emilia, Italy (P.G.-R.); Casablanca Cancer Registry, Casablanca, Morocco (K.B.); Center for the Study of the State and Society (S.A.), and National Scientific and Technical Research Council (S.A.), Buenos Aires, Argentina; Chinese Academy of Medical Sciences, Beijing, China (F.Z.); Hospital Clínic de Barcelona, Barcelona, Spain (M.d.P.); Hospital Universitario San Ignacio, Bogota, Colombia (R.M.); International Agency for Research on Cancer, Lyon (V.B., W.P., B.I.I.R., I.M.-M., B.L.-S.); Karolinska Institutet, Stockholm, Sweden (M.E.); McGill University, Montreal, Quebec, Canada (E.L.F.); National Cancer Institute, Bangkok, Thailand (S.S.); National Cancer Institute, Rockville, MD (N.W., M. Schiffman); National Public Health Agency, Saint-Maurice (F.F.H.), France; PATH, Seattle, WA (S.d.S.); Public Health England and Screening, London, United Kingdom (A.M.); Research Triangle Institute International, New Delhi, India (R. Sankaranarayanan); Teikyo University (C.H.), and National Cancer Center (C.H.), Tokyo, Japan; The Daffodil Centre, a joint venture between the Cancer Council NSW and the University of Sydney, King's Cross, New South Wales, Australia (K.C.); University of Edinburgh, Edinburgh, United Kingdom (C.S.H.); University of Toronto, Toronto, Ontario, Canada (R.K.); University of Zimbabwe College of Health Sciences, Harare, Zimbabwe (Z.M.C.); VCS Foundation, Melbourne, Victoria, Australia (J. Brotherton); and Sciensano, Brussels, Belgium (M.A.)Robert A. SmithAmerican Cancer Society (R. Smith), Emory University (M.H.C.), and Centers for Disease Control and Prevention (M. Saraiya), Atlanta, GA; Amsterdam University Medical Centers, Amsterdam, the Netherlands (J. Berkhof); Azienda Unità Sanitaria Locale, IRCCS Reggio Emilia, Reggio Emilia, Italy (P.G.-R.); Casablanca Cancer Registry, Casablanca, Morocco (K.B.); Center for the Study of the State and Society (S.A.), and National Scientific and Technical Research Council (S.A.), Buenos Aires, Argentina; Chinese Academy of Medical Sciences, Beijing, China (F.Z.); Hospital Clínic de Barcelona, Barcelona, Spain (M.d.P.); Hospital Universitario San Ignacio, Bogota, Colombia (R.M.); International Agency for Research on Cancer, Lyon (V.B., W.P., B.I.I.R., I.M.-M., B.L.-S.); Karolinska Institutet, Stockholm, Sweden (M.E.); McGill University, Montreal, Quebec, Canada (E.L.F.); National Cancer Institute, Bangkok, Thailand (S.S.); National Cancer Institute, Rockville, MD (N.W., M. Schiffman); National Public Health Agency, Saint-Maurice (F.F.H.), France; PATH, Seattle, WA (S.d.S.); Public Health England and Screening, London, United Kingdom (A.M.); Research Triangle Institute International, New Delhi, India (R. Sankaranarayanan); Teikyo University (C.H.), and National Cancer Center (C.H.), Tokyo, Japan; The Daffodil Centre, a joint venture between the Cancer Council NSW and the University of Sydney, King's Cross, New South Wales, Australia (K.C.); University of Edinburgh, Edinburgh, United Kingdom (C.S.H.); University of Toronto, Toronto, Ontario, Canada (R.K.); University of Zimbabwe College of Health Sciences, Harare, Zimbabwe (Z.M.C.); VCS Foundation, Melbourne, Victoria, Australia (J. Brotherton); and Sciensano, Brussels, Belgium (M.A.)Silvina ArrossiAmerican Cancer Society (R. Smith), Emory University (M.H.C.), and Centers for Disease Control and Prevention (M. Saraiya), Atlanta, GA; Amsterdam University Medical Centers, Amsterdam, the Netherlands (J. Berkhof); Azienda Unità Sanitaria Locale, IRCCS Reggio Emilia, Reggio Emilia, Italy (P.G.-R.); Casablanca Cancer Registry, Casablanca, Morocco (K.B.); Center for the Study of the State and Society (S.A.), and National Scientific and Technical Research Council (S.A.), Buenos Aires, Argentina; Chinese Academy of Medical Sciences, Beijing, China (F.Z.); Hospital Clínic de Barcelona, Barcelona, Spain (M.d.P.); Hospital Universitario San Ignacio, Bogota, Colombia (R.M.); International Agency for Research on Cancer, Lyon (V.B., W.P., B.I.I.R., I.M.-M., B.L.-S.); Karolinska Institutet, Stockholm, Sweden (M.E.); McGill University, Montreal, Quebec, Canada (E.L.F.); National Cancer Institute, Bangkok, Thailand (S.S.); National Cancer Institute, Rockville, MD (N.W., M. Schiffman); National Public Health Agency, Saint-Maurice (F.F.H.), France; PATH, Seattle, WA (S.d.S.); Public Health England and Screening, London, United Kingdom (A.M.); Research Triangle Institute International, New Delhi, India (R. Sankaranarayanan); Teikyo University (C.H.), and National Cancer Center (C.H.), Tokyo, Japan; The Daffodil Centre, a joint venture between the Cancer Council NSW and the University of Sydney, King's Cross, New South Wales, Australia (K.C.); University of Edinburgh, Edinburgh, United Kingdom (C.S.H.); University of Toronto, Toronto, Ontario, Canada (R.K.); University of Zimbabwe College of Health Sciences, Harare, Zimbabwe (Z.M.C.); VCS Foundation, Melbourne, Victoria, Australia (J. Brotherton); and Sciensano, Brussels, Belgium (M.A.)Karima BendahhouAmerican Cancer Society (R. Smith), Emory University (M.H.C.), and Centers for Disease Control and Prevention (M. Saraiya), Atlanta, GA; Amsterdam University Medical Centers, Amsterdam, the Netherlands (J. Berkhof); Azienda Unità Sanitaria Locale, IRCCS Reggio Emilia, Reggio Emilia, Italy (P.G.-R.); Casablanca Cancer Registry, Casablanca, Morocco (K.B.); Center for the Study of the State and Society (S.A.), and National Scientific and Technical Research Council (S.A.), Buenos Aires, Argentina; Chinese Academy of Medical Sciences, Beijing, China (F.Z.); Hospital Clínic de Barcelona, Barcelona, Spain (M.d.P.); Hospital Universitario San Ignacio, Bogota, Colombia (R.M.); International Agency for Research on Cancer, Lyon (V.B., W.P., B.I.I.R., I.M.-M., B.L.-S.); Karolinska Institutet, Stockholm, Sweden (M.E.); McGill University, Montreal, Quebec, Canada (E.L.F.); National Cancer Institute, Bangkok, Thailand (S.S.); National Cancer Institute, Rockville, MD (N.W., M. Schiffman); National Public Health Agency, Saint-Maurice (F.F.H.), France; PATH, Seattle, WA (S.d.S.); Public Health England and Screening, London, United Kingdom (A.M.); Research Triangle Institute International, New Delhi, India (R. Sankaranarayanan); Teikyo University (C.H.), and National Cancer Center (C.H.), Tokyo, Japan; The Daffodil Centre, a joint venture between the Cancer Council NSW and the University of Sydney, King's Cross, New South Wales, Australia (K.C.); University of Edinburgh, Edinburgh, United Kingdom (C.S.H.); University of Toronto, Toronto, Ontario, Canada (R.K.); University of Zimbabwe College of Health Sciences, Harare, Zimbabwe (Z.M.C.); VCS Foundation, Melbourne, Victoria, Australia (J. Brotherton); and Sciensano, Brussels, Belgium (M.A.)Karen CanfellAmerican Cancer Society (R. Smith), Emory University (M.H.C.), and Centers for Disease Control and Prevention (M. Saraiya), Atlanta, GA; Amsterdam University Medical Centers, Amsterdam, the Netherlands (J. Berkhof); Azienda Unità Sanitaria Locale, IRCCS Reggio Emilia, Reggio Emilia, Italy (P.G.-R.); Casablanca Cancer Registry, Casablanca, Morocco (K.B.); Center for the Study of the State and Society (S.A.), and National Scientific and Technical Research Council (S.A.), Buenos Aires, Argentina; Chinese Academy of Medical Sciences, Beijing, China (F.Z.); Hospital Clínic de Barcelona, Barcelona, Spain (M.d.P.); Hospital Universitario San Ignacio, Bogota, Colombia (R.M.); International Agency for Research on Cancer, Lyon (V.B., W.P., B.I.I.R., I.M.-M., B.L.-S.); Karolinska Institutet, Stockholm, Sweden (M.E.); McGill University, Montreal, Quebec, Canada (E.L.F.); National Cancer Institute, Bangkok, Thailand (S.S.); National Cancer Institute, Rockville, MD (N.W., M. Schiffman); National Public Health Agency, Saint-Maurice (F.F.H.), France; PATH, Seattle, WA (S.d.S.); Public Health England and Screening, London, United Kingdom (A.M.); Research Triangle Institute International, New Delhi, India (R. Sankaranarayanan); Teikyo University (C.H.), and National Cancer Center (C.H.), Tokyo, Japan; The Daffodil Centre, a joint venture between the Cancer Council NSW and the University of Sydney, King's Cross, New South Wales, Australia (K.C.); University of Edinburgh, Edinburgh, United Kingdom (C.S.H.); University of Toronto, Toronto, Ontario, Canada (R.K.); University of Zimbabwe College of Health Sciences, Harare, Zimbabwe (Z.M.C.); VCS Foundation, Melbourne, Victoria, Australia (J. Brotherton); and Sciensano, Brussels, Belgium (M.A.)Zvavahera M. ChirenjeAmerican Cancer Society (R. Smith), Emory University (M.H.C.), and Centers for Disease Control and Prevention (M. Saraiya), Atlanta, GA; Amsterdam University Medical Centers, Amsterdam, the Netherlands (J. Berkhof); Azienda Unità Sanitaria Locale, IRCCS Reggio Emilia, Reggio Emilia, Italy (P.G.-R.); Casablanca Cancer Registry, Casablanca, Morocco (K.B.); Center for the Study of the State and Society (S.A.), and National Scientific and Technical Research Council (S.A.), Buenos Aires, Argentina; Chinese Academy of Medical Sciences, Beijing, China (F.Z.); Hospital Clínic de Barcelona, Barcelona, Spain (M.d.P.); Hospital Universitario San Ignacio, Bogota, Colombia (R.M.); International Agency for Research on Cancer, Lyon (V.B., W.P., B.I.I.R., I.M.-M., B.L.-S.); Karolinska Institutet, Stockholm, Sweden (M.E.); McGill University, Montreal, Quebec, Canada (E.L.F.); National Cancer Institute, Bangkok, Thailand (S.S.); National Cancer Institute, Rockville, MD (N.W., M. Schiffman); National Public Health Agency, Saint-Maurice (F.F.H.), France; PATH, Seattle, WA (S.d.S.); Public Health England and Screening, London, United Kingdom (A.M.); Research Triangle Institute International, New Delhi, India (R. Sankaranarayanan); Teikyo University (C.H.), and National Cancer Center (C.H.), Tokyo, Japan; The Daffodil Centre, a joint venture between the Cancer Council NSW and the University of Sydney, King's Cross, New South Wales, Australia (K.C.); University of Edinburgh, Edinburgh, United Kingdom (C.S.H.); University of Toronto, Toronto, Ontario, Canada (R.K.); University of Zimbabwe College of Health Sciences, Harare, Zimbabwe (Z.M.C.); VCS Foundation, Melbourne, Victoria, Australia (J. Brotherton); and Sciensano, Brussels, Belgium (M.A.)Michael H. ChungAmerican Cancer Society (R. Smith), Emory University (M.H.C.), and Centers for Disease Control and Prevention (M. Saraiya), Atlanta, GA; Amsterdam University Medical Centers, Amsterdam, the Netherlands (J. Berkhof); Azienda Unità Sanitaria Locale, IRCCS Reggio Emilia, Reggio Emilia, Italy (P.G.-R.); Casablanca Cancer Registry, Casablanca, Morocco (K.B.); Center for the Study of the State and Society (S.A.), and National Scientific and Technical Research Council (S.A.), Buenos Aires, Argentina; Chinese Academy of Medical Sciences, Beijing, China (F.Z.); Hospital Clínic de Barcelona, Barcelona, Spain (M.d.P.); Hospital Universitario San Ignacio, Bogota, Colombia (R.M.); International Agency for Research on Cancer, Lyon (V.B., W.P., B.I.I.R., I.M.-M., B.L.-S.); Karolinska Institutet, Stockholm, Sweden (M.E.); McGill University, Montreal, Quebec, Canada (E.L.F.); National Cancer Institute, Bangkok, Thailand (S.S.); National Cancer Institute, Rockville, MD (N.W., M. Schiffman); National Public Health Agency, Saint-Maurice (F.F.H.), France; PATH, Seattle, WA (S.d.S.); Public Health England and Screening, London, United Kingdom (A.M.); Research Triangle Institute International, New Delhi, India (R. Sankaranarayanan); Teikyo University (C.H.), and National Cancer Center (C.H.), Tokyo, Japan; The Daffodil Centre, a joint venture between the Cancer Council NSW and the University of Sydney, King's Cross, New South Wales, Australia (K.C.); University of Edinburgh, Edinburgh, United Kingdom (C.S.H.); University of Toronto, Toronto, Ontario, Canada (R.K.); University of Zimbabwe College of Health Sciences, Harare, Zimbabwe (Z.M.C.); VCS Foundation, Melbourne, Victoria, Australia (J. Brotherton); and Sciensano, Brussels, Belgium (M.A.)Marta del PinoAmerican Cancer Society (R. Smith), Emory University (M.H.C.), and Centers for Disease Control and Prevention (M. Saraiya), Atlanta, GA; Amsterdam University Medical Centers, Amsterdam, the Netherlands (J. Berkhof); Azienda Unità Sanitaria Locale, IRCCS Reggio Emilia, Reggio Emilia, Italy (P.G.-R.); Casablanca Cancer Registry, Casablanca, Morocco (K.B.); Center for the Study of the State and Society (S.A.), and National Scientific and Technical Research Council (S.A.), Buenos Aires, Argentina; Chinese Academy of Medical Sciences, Beijing, China (F.Z.); Hospital Clínic de Barcelona, Barcelona, Spain (M.d.P.); Hospital Universitario San Ignacio, Bogota, Colombia (R.M.); International Agency for Research on Cancer, Lyon (V.B., W.P., B.I.I.R., I.M.-M., B.L.-S.); Karolinska Institutet, Stockholm, Sweden (M.E.); McGill University, Montreal, Quebec, Canada (E.L.F.); National Cancer Institute, Bangkok, Thailand (S.S.); National Cancer Institute, Rockville, MD (N.W., M. Schiffman); National Public Health Agency, Saint-Maurice (F.F.H.), France; PATH, Seattle, WA (S.d.S.); Public Health England and Screening, London, United Kingdom (A.M.); Research Triangle Institute International, New Delhi, India (R. Sankaranarayanan); Teikyo University (C.H.), and National Cancer Center (C.H.), Tokyo, Japan; The Daffodil Centre, a joint venture between the Cancer Council NSW and the University of Sydney, King's Cross, New South Wales, Australia (K.C.); University of Edinburgh, Edinburgh, United Kingdom (C.S.H.); University of Toronto, Toronto, Ontario, Canada (R.K.); University of Zimbabwe College of Health Sciences, Harare, Zimbabwe (Z.M.C.); VCS Foundation, Melbourne, Victoria, Australia (J. Brotherton); and Sciensano, Brussels, Belgium (M.A.)Silvia de SanjoséAmerican Cancer Society (R. Smith), Emory University (M.H.C.), and Centers for Disease Control and Prevention (M. Saraiya), Atlanta, GA; Amsterdam University Medical Centers, Amsterdam, the Netherlands (J. Berkhof); Azienda Unità Sanitaria Locale, IRCCS Reggio Emilia, Reggio Emilia, Italy (P.G.-R.); Casablanca Cancer Registry, Casablanca, Morocco (K.B.); Center for the Study of the State and Society (S.A.), and National Scientific and Technical Research Council (S.A.), Buenos Aires, Argentina; Chinese Academy of Medical Sciences, Beijing, China (F.Z.); Hospital Clínic de Barcelona, Barcelona, Spain (M.d.P.); Hospital Universitario San Ignacio, Bogota, Colombia (R.M.); International Agency for Research on Cancer, Lyon (V.B., W.P., B.I.I.R., I.M.-M., B.L.-S.); Karolinska Institutet, Stockholm, Sweden (M.E.); McGill University, Montreal, Quebec, Canada (E.L.F.); National Cancer Institute, Bangkok, Thailand (S.S.); National Cancer Institute, Rockville, MD (N.W., M. Schiffman); National Public Health Agency, Saint-Maurice (F.F.H.), France; PATH, Seattle, WA (S.d.S.); Public Health England and Screening, London, United Kingdom (A.M.); Research Triangle Institute International, New Delhi, India (R. Sankaranarayanan); Teikyo University (C.H.), and National Cancer Center (C.H.), Tokyo, Japan; The Daffodil Centre, a joint venture between the Cancer Council NSW and the University of Sydney, King's Cross, New South Wales, Australia (K.C.); University of Edinburgh, Edinburgh, United Kingdom (C.S.H.); University of Toronto, Toronto, Ontario, Canada (R.K.); University of Zimbabwe College of Health Sciences, Harare, Zimbabwe (Z.M.C.); VCS Foundation, Melbourne, Victoria, Australia (J. Brotherton); and Sciensano, Brussels, Belgium (M.A.)Miriam ElfströmAmerican Cancer Society (R. Smith), Emory University (M.H.C.), and Centers for Disease Control and Prevention (M. Saraiya), Atlanta, GA; Amsterdam University Medical Centers, Amsterdam, the Netherlands (J. Berkhof); Azienda Unità Sanitaria Locale, IRCCS Reggio Emilia, Reggio Emilia, Italy (P.G.-R.); Casablanca Cancer Registry, Casablanca, Morocco (K.B.); Center for the Study of the State and Society (S.A.), and National Scientific and Technical Research Council (S.A.), Buenos Aires, Argentina; Chinese Academy of Medical Sciences, Beijing, China (F.Z.); Hospital Clínic de Barcelona, Barcelona, Spain (M.d.P.); Hospital Universitario San Ignacio, Bogota, Colombia (R.M.); International Agency for Research on Cancer, Lyon (V.B., W.P., B.I.I.R., I.M.-M., B.L.-S.); Karolinska Institutet, Stockholm, Sweden (M.E.); McGill University, Montreal, Quebec, Canada (E.L.F.); National Cancer Institute, Bangkok, Thailand (S.S.); National Cancer Institute, Rockville, MD (N.W., M. Schiffman); National Public Health Agency, Saint-Maurice (F.F.H.), France; PATH, Seattle, WA (S.d.S.); Public Health England and Screening, London, United Kingdom (A.M.); Research Triangle Institute International, New Delhi, India (R. Sankaranarayanan); Teikyo University (C.H.), and National Cancer Center (C.H.), Tokyo, Japan; The Daffodil Centre, a joint venture between the Cancer Council NSW and the University of Sydney, King's Cross, New South Wales, Australia (K.C.); University of Edinburgh, Edinburgh, United Kingdom (C.S.H.); University of Toronto, Toronto, Ontario, Canada (R.K.); University of Zimbabwe College of Health Sciences, Harare, Zimbabwe (Z.M.C.); VCS Foundation, Melbourne, Victoria, Australia (J. Brotherton); and Sciensano, Brussels, Belgium (M.A.)Eduardo L. FrancoAmerican Cancer Society (R. Smith), Emory University (M.H.C.), and Centers for Disease Control and Prevention (M. Saraiya), Atlanta, GA; Amsterdam University Medical Centers, Amsterdam, the Netherlands (J. Berkhof); Azienda Unità Sanitaria Locale, IRCCS Reggio Emilia, Reggio Emilia, Italy (P.G.-R.); Casablanca Cancer Registry, Casablanca, Morocco (K.B.); Center for the Study of the State and Society (S.A.), and National Scientific and Technical Research Council (S.A.), Buenos Aires, Argentina; Chinese Academy of Medical Sciences, Beijing, China (F.Z.); Hospital Clínic de Barcelona, Barcelona, Spain (M.d.P.); Hospital Universitario San Ignacio, Bogota, Colombia (R.M.); International Agency for Research on Cancer, Lyon (V.B., W.P., B.I.I.R., I.M.-M., B.L.-S.); Karolinska Institutet, Stockholm, Sweden (M.E.); McGill University, Montreal, Quebec, Canada (E.L.F.); National Cancer Institute, Bangkok, Thailand (S.S.); National Cancer Institute, Rockville, MD (N.W., M. Schiffman); National Public Health Agency, Saint-Maurice (F.F.H.), France; PATH, Seattle, WA (S.d.S.); Public Health England and Screening, London, United Kingdom (A.M.); Research Triangle Institute International, New Delhi, India (R. Sankaranarayanan); Teikyo University (C.H.), and National Cancer Center (C.H.), Tokyo, Japan; The Daffodil Centre, a joint venture between the Cancer Council NSW and the University of Sydney, King's Cross, New South Wales, Australia (K.C.); University of Edinburgh, Edinburgh, United Kingdom (C.S.H.); University of Toronto, Toronto, Ontario, Canada (R.K.); University of Zimbabwe College of Health Sciences, Harare, Zimbabwe (Z.M.C.); VCS Foundation, Melbourne, Victoria, Australia (J. Brotherton); and Sciensano, Brussels, Belgium (M.A.)Chisato HamashimaAmerican Cancer Society (R. Smith), Emory University (M.H.C.), and Centers for Disease Control and Prevention (M. Saraiya), Atlanta, GA; Amsterdam University Medical Centers, Amsterdam, the Netherlands (J. Berkhof); Azienda Unità Sanitaria Locale, IRCCS Reggio Emilia, Reggio Emilia, Italy (P.G.-R.); Casablanca Cancer Registry, Casablanca, Morocco (K.B.); Center for the Study of the State and Society (S.A.), and National Scientific and Technical Research Council (S.A.), Buenos Aires, Argentina; Chinese Academy of Medical Sciences, Beijing, China (F.Z.); Hospital Clínic de Barcelona, Barcelona, Spain (M.d.P.); Hospital Universitario San Ignacio, Bogota, Colombia (R.M.); International Agency for Research on Cancer, Lyon (V.B., W.P., B.I.I.R., I.M.-M., B.L.-S.); Karolinska Institutet, Stockholm, Sweden (M.E.); McGill University, Montreal, Quebec, Canada (E.L.F.); National Cancer Institute, Bangkok, Thailand (S.S.); National Cancer Institute, Rockville, MD (N.W., M. Schiffman); National Public Health Agency, Saint-Maurice (F.F.H.), France; PATH, Seattle, WA (S.d.S.); Public Health England and Screening, London, United Kingdom (A.M.); Research Triangle Institute International, New Delhi, India (R. Sankaranarayanan); Teikyo University (C.H.), and National Cancer Center (C.H.), Tokyo, Japan; The Daffodil Centre, a joint venture between the Cancer Council NSW and the University of Sydney, King's Cross, New South Wales, Australia (K.C.); University of Edinburgh, Edinburgh, United Kingdom (C.S.H.); University of Toronto, Toronto, Ontario, Canada (R.K.); University of Zimbabwe College of Health Sciences, Harare, Zimbabwe (Z.M.C.); VCS Foundation, Melbourne, Victoria, Australia (J. Brotherton); and Sciensano, Brussels, Belgium (M.A.)F F HamersAmerican Cancer Society (R. Smith), Emory University (M.H.C.), and Centers for Disease Control and Prevention (M. Saraiya), Atlanta, GA; Amsterdam University Medical Centers, Amsterdam, the Netherlands (J. Berkhof); Azienda Unità Sanitaria Locale, IRCCS Reggio Emilia, Reggio Emilia, Italy (P.G.-R.); Casablanca Cancer Registry, Casablanca, Morocco (K.B.); Center for the Study of the State and Society (S.A.), and National Scientific and Technical Research Council (S.A.), Buenos Aires, Argentina; Chinese Academy of Medical Sciences, Beijing, China (F.Z.); Hospital Clínic de Barcelona, Barcelona, Spain (M.d.P.); Hospital Universitario San Ignacio, Bogota, Colombia (R.M.); International Agency for Research on Cancer, Lyon (V.B., W.P., B.I.I.R., I.M.-M., B.L.-S.); Karolinska Institutet, Stockholm, Sweden (M.E.); McGill University, Montreal, Quebec, Canada (E.L.F.); National Cancer Institute, Bangkok, Thailand (S.S.); National Cancer Institute, Rockville, MD (N.W., M. Schiffman); National Public Health Agency, Saint-Maurice (F.F.H.), France; PATH, Seattle, WA (S.d.S.); Public Health England and Screening, London, United Kingdom (A.M.); Research Triangle Institute International, New Delhi, India (R. Sankaranarayanan); Teikyo University (C.H.), and National Cancer Center (C.H.), Tokyo, Japan; The Daffodil Centre, a joint venture between the Cancer Council NSW and the University of Sydney, King's Cross, New South Wales, Australia (K.C.); University of Edinburgh, Edinburgh, United Kingdom (C.S.H.); University of Toronto, Toronto, Ontario, Canada (R.K.); University of Zimbabwe College of Health Sciences, Harare, Zimbabwe (Z.M.C.); VCS Foundation, Melbourne, Victoria, Australia (J. Brotherton); and Sciensano, Brussels, Belgium (M.A.)C. Simon HerringtonAmerican Cancer Society (R. Smith), Emory University (M.H.C.), and Centers for Disease Control and Prevention (M. Saraiya), Atlanta, GA; Amsterdam University Medical Centers, Amsterdam, the Netherlands (J. Berkhof); Azienda Unità Sanitaria Locale, IRCCS Reggio Emilia, Reggio Emilia, Italy (P.G.-R.); Casablanca Cancer Registry, Casablanca, Morocco (K.B.); Center for the Study of the State and Society (S.A.), and National Scientific and Technical Research Council (S.A.), Buenos Aires, Argentina; Chinese Academy of Medical Sciences, Beijing, China (F.Z.); Hospital Clínic de Barcelona, Barcelona, Spain (M.d.P.); Hospital Universitario San Ignacio, Bogota, Colombia (R.M.); International Agency for Research on Cancer, Lyon (V.B., W.P., B.I.I.R., I.M.-M., B.L.-S.); Karolinska Institutet, Stockholm, Sweden (M.E.); McGill University, Montreal, Quebec, Canada (E.L.F.); National Cancer Institute, Bangkok, Thailand (S.S.); National Cancer Institute, Rockville, MD (N.W., M. Schiffman); National Public Health Agency, Saint-Maurice (F.F.H.), France; PATH, Seattle, WA (S.d.S.); Public Health England and Screening, London, United Kingdom (A.M.); Research Triangle Institute International, New Delhi, India (R. Sankaranarayanan); Teikyo University (C.H.), and National Cancer Center (C.H.), Tokyo, Japan; The Daffodil Centre, a joint venture between the Cancer Council NSW and the University of Sydney, King's Cross, New South Wales, Australia (K.C.); University of Edinburgh, Edinburgh, United Kingdom (C.S.H.); University of Toronto, Toronto, Ontario, Canada (R.K.); University of Zimbabwe College of Health Sciences, Harare, Zimbabwe (Z.M.C.); VCS Foundation, Melbourne, Victoria, Australia (J. Brotherton); and Sciensano, Brussels, Belgium (M.A.)Raúl MurilloAmerican Cancer Society (R. Smith), Emory University (M.H.C.), and Centers for Disease Control and Prevention (M. Saraiya), Atlanta, GA; Amsterdam University Medical Centers, Amsterdam, the Netherlands (J. Berkhof); Azienda Unità Sanitaria Locale, IRCCS Reggio Emilia, Reggio Emilia, Italy (P.G.-R.); Casablanca Cancer Registry, Casablanca, Morocco (K.B.); Center for the Study of the State and Society (S.A.), and National Scientific and Technical Research Council (S.A.), Buenos Aires, Argentina; Chinese Academy of Medical Sciences, Beijing, China (F.Z.); Hospital Clínic de Barcelona, Barcelona, Spain (M.d.P.); Hospital Universitario San Ignacio, Bogota, Colombia (R.M.); International Agency for Research on Cancer, Lyon (V.B., W.P., B.I.I.R., I.M.-M., B.L.-S.); Karolinska Institutet, Stockholm, Sweden (M.E.); McGill University, Montreal, Quebec, Canada (E.L.F.); National Cancer Institute, Bangkok, Thailand (S.S.); National Cancer Institute, Rockville, MD (N.W., M. Schiffman); National Public Health Agency, Saint-Maurice (F.F.H.), France; PATH, Seattle, WA (S.d.S.); Public Health England and Screening, London, United Kingdom (A.M.); Research Triangle Institute International, New Delhi, India (R. Sankaranarayanan); Teikyo University (C.H.), and National Cancer Center (C.H.), Tokyo, Japan; The Daffodil Centre, a joint venture between the Cancer Council NSW and the University of Sydney, King's Cross, New South Wales, Australia (K.C.); University of Edinburgh, Edinburgh, United Kingdom (C.S.H.); University of Toronto, Toronto, Ontario, Canada (R.K.); University of Zimbabwe College of Health Sciences, Harare, Zimbabwe (Z.M.C.); VCS Foundation, Melbourne, Victoria, Australia (J. Brotherton); and Sciensano, Brussels, Belgium (M.A.)Suleeporn SangrajrangAmerican Cancer Society (R. Smith), Emory University (M.H.C.), and Centers for Disease Control and Prevention (M. Saraiya), Atlanta, GA; Amsterdam University Medical Centers, Amsterdam, the Netherlands (J. Berkhof); Azienda Unità Sanitaria Locale, IRCCS Reggio Emilia, Reggio Emilia, Italy (P.G.-R.); Casablanca Cancer Registry, Casablanca, Morocco (K.B.); Center for the Study of the State and Society (S.A.), and National Scientific and Technical Research Council (S.A.), Buenos Aires, Argentina; Chinese Academy of Medical Sciences, Beijing, China (F.Z.); Hospital Clínic de Barcelona, Barcelona, Spain (M.d.P.); Hospital Universitario San Ignacio, Bogota, Colombia (R.M.); International Agency for Research on Cancer, Lyon (V.B., W.P., B.I.I.R., I.M.-M., B.L.-S.); Karolinska Institutet, Stockholm, Sweden (M.E.); McGill University, Montreal, Quebec, Canada (E.L.F.); National Cancer Institute, Bangkok, Thailand (S.S.); National Cancer Institute, Rockville, MD (N.W., M. Schiffman); National Public Health Agency, Saint-Maurice (F.F.H.), France; PATH, Seattle, WA (S.d.S.); Public Health England and Screening, London, United Kingdom (A.M.); Research Triangle Institute International, New Delhi, India (R. Sankaranarayanan); Teikyo University (C.H.), and National Cancer Center (C.H.), Tokyo, Japan; The Daffodil Centre, a joint venture between the Cancer Council NSW and the University of Sydney, King's Cross, New South Wales, Australia (K.C.); University of Edinburgh, Edinburgh, United Kingdom (C.S.H.); University of Toronto, Toronto, Ontario, Canada (R.K.); University of Zimbabwe College of Health Sciences, Harare, Zimbabwe (Z.M.C.); VCS Foundation, Melbourne, Victoria, Australia (J. Brotherton); and Sciensano, Brussels, Belgium (M.A.)Rengaswamy SankaranarayananAmerican Cancer Society (R. Smith), Emory University (M.H.C.), and Centers for Disease Control and Prevention (M. Saraiya), Atlanta, GA; Amsterdam University Medical Centers, Amsterdam, the Netherlands (J. Berkhof); Azienda Unità Sanitaria Locale, IRCCS Reggio Emilia, Reggio Emilia, Italy (P.G.-R.); Casablanca Cancer Registry, Casablanca, Morocco (K.B.); Center for the Study of the State and Society (S.A.), and National Scientific and Technical Research Council (S.A.), Buenos Aires, Argentina; Chinese Academy of Medical Sciences, Beijing, China (F.Z.); Hospital Clínic de Barcelona, Barcelona, Spain (M.d.P.); Hospital Universitario San Ignacio, Bogota, Colombia (R.M.); International Agency for Research on Cancer, Lyon (V.B., W.P., B.I.I.R., I.M.-M., B.L.-S.); Karolinska Institutet, Stockholm, Sweden (M.E.); McGill University, Montreal, Quebec, Canada (E.L.F.); National Cancer Institute, Bangkok, Thailand (S.S.); National Cancer Institute, Rockville, MD (N.W., M. Schiffman); National Public Health Agency, Saint-Maurice (F.F.H.), France; PATH, Seattle, WA (S.d.S.); Public Health England and Screening, London, United Kingdom (A.M.); Research Triangle Institute International, New Delhi, India (R. Sankaranarayanan); Teikyo University (C.H.), and National Cancer Center (C.H.), Tokyo, Japan; The Daffodil Centre, a joint venture between the Cancer Council NSW and the University of Sydney, King's Cross, New South Wales, Australia (K.C.); University of Edinburgh, Edinburgh, United Kingdom (C.S.H.); University of Toronto, Toronto, Ontario, Canada (R.K.); University of Zimbabwe College of Health Sciences, Harare, Zimbabwe (Z.M.C.); VCS Foundation, Melbourne, Victoria, Australia (J. Brotherton); and Sciensano, Brussels, Belgium (M.A.)Mona SaraiyaAmerican Cancer Society (R. Smith), Emory University (M.H.C.), and Centers for Disease Control and Prevention (M. Saraiya), Atlanta, GA; Amsterdam University Medical Centers, Amsterdam, the Netherlands (J. Berkhof); Azienda Unità Sanitaria Locale, IRCCS Reggio Emilia, Reggio Emilia, Italy (P.G.-R.); Casablanca Cancer Registry, Casablanca, Morocco (K.B.); Center for the Study of the State and Society (S.A.), and National Scientific and Technical Research Council (S.A.), Buenos Aires, Argentina; Chinese Academy of Medical Sciences, Beijing, China (F.Z.); Hospital Clínic de Barcelona, Barcelona, Spain (M.d.P.); Hospital Universitario San Ignacio, Bogota, Colombia (R.M.); International Agency for Research on Cancer, Lyon (V.B., W.P., B.I.I.R., I.M.-M., B.L.-S.); Karolinska Institutet, Stockholm, Sweden (M.E.); McGill University, Montreal, Quebec, Canada (E.L.F.); National Cancer Institute, Bangkok, Thailand (S.S.); National Cancer Institute, Rockville, MD (N.W., M. Schiffman); National Public Health Agency, Saint-Maurice (F.F.H.), France; PATH, Seattle, WA (S.d.S.); Public Health England and Screening, London, United Kingdom (A.M.); Research Triangle Institute International, New Delhi, India (R. Sankaranarayanan); Teikyo University (C.H.), and National Cancer Center (C.H.), Tokyo, Japan; The Daffodil Centre, a joint venture between the Cancer Council NSW and the University of Sydney, King's Cross, New South Wales, Australia (K.C.); University of Edinburgh, Edinburgh, United Kingdom (C.S.H.); University of Toronto, Toronto, Ontario, Canada (R.K.); University of Zimbabwe College of Health Sciences, Harare, Zimbabwe (Z.M.C.); VCS Foundation, Melbourne, Victoria, Australia (J. Brotherton); and Sciensano, Brussels, Belgium (M.A.)Mark SchiffmanAmerican Cancer Society (R. Smith), Emory University (M.H.C.), and Centers for Disease Control and Prevention (M. Saraiya), Atlanta, GA; Amsterdam University Medical Centers, Amsterdam, the Netherlands (J. Berkhof); Azienda Unità Sanitaria Locale, IRCCS Reggio Emilia, Reggio Emilia, Italy (P.G.-R.); Casablanca Cancer Registry, Casablanca, Morocco (K.B.); Center for the Study of the State and Society (S.A.), and National Scientific and Technical Research Council (S.A.), Buenos Aires, Argentina; Chinese Academy of Medical Sciences, Beijing, China (F.Z.); Hospital Clínic de Barcelona, Barcelona, Spain (M.d.P.); Hospital Universitario San Ignacio, Bogota, Colombia (R.M.); International Agency for Research on Cancer, Lyon (V.B., W.P., B.I.I.R., I.M.-M., B.L.-S.); Karolinska Institutet, Stockholm, Sweden (M.E.); McGill University, Montreal, Quebec, Canada (E.L.F.); National Cancer Institute, Bangkok, Thailand (S.S.); National Cancer Institute, Rockville, MD (N.W., M. Schiffman); National Public Health Agency, Saint-Maurice (F.F.H.), France; PATH, Seattle, WA (S.d.S.); Public Health England and Screening, London, United Kingdom (A.M.); Research Triangle Institute International, New Delhi, India (R. Sankaranarayanan); Teikyo University (C.H.), and National Cancer Center (C.H.), Tokyo, Japan; The Daffodil Centre, a joint venture between the Cancer Council NSW and the University of Sydney, King's Cross, New South Wales, Australia (K.C.); University of Edinburgh, Edinburgh, United Kingdom (C.S.H.); University of Toronto, Toronto, Ontario, Canada (R.K.); University of Zimbabwe College of Health Sciences, Harare, Zimbabwe (Z.M.C.); VCS Foundation, Melbourne, Victoria, Australia (J. Brotherton); and Sciensano, Brussels, Belgium (M.A.)Fanghui ZhaoAmerican Cancer Society (R. Smith), Emory University (M.H.C.), and Centers for Disease Control and Prevention (M. Saraiya), Atlanta, GA; Amsterdam University Medical Centers, Amsterdam, the Netherlands (J. Berkhof); Azienda Unità Sanitaria Locale, IRCCS Reggio Emilia, Reggio Emilia, Italy (P.G.-R.); Casablanca Cancer Registry, Casablanca, Morocco (K.B.); Center for the Study of the State and Society (S.A.), and National Scientific and Technical Research Council (S.A.), Buenos Aires, Argentina; Chinese Academy of Medical Sciences, Beijing, China (F.Z.); Hospital Clínic de Barcelona, Barcelona, Spain (M.d.P.); Hospital Universitario San Ignacio, Bogota, Colombia (R.M.); International Agency for Research on Cancer, Lyon (V.B., W.P., B.I.I.R., I.M.-M., B.L.-S.); Karolinska Institutet, Stockholm, Sweden (M.E.); McGill University, Montreal, Quebec, Canada (E.L.F.); National Cancer Institute, Bangkok, Thailand (S.S.); National Cancer Institute, Rockville, MD (N.W., M. Schiffman); National Public Health Agency, Saint-Maurice (F.F.H.), France; PATH, Seattle, WA (S.d.S.); Public Health England and Screening, London, United Kingdom (A.M.); Research Triangle Institute International, New Delhi, India (R. Sankaranarayanan); Teikyo University (C.H.), and National Cancer Center (C.H.), Tokyo, Japan; The Daffodil Centre, a joint venture between the Cancer Council NSW and the University of Sydney, King's Cross, New South Wales, Australia (K.C.); University of Edinburgh, Edinburgh, United Kingdom (C.S.H.); University of Toronto, Toronto, Ontario, Canada (R.K.); University of Zimbabwe College of Health Sciences, Harare, Zimbabwe (Z.M.C.); VCS Foundation, Melbourne, Victoria, Australia (J. Brotherton); and Sciensano, Brussels, Belgium (M.A.)Marc ArbynAmerican Cancer Society (R. Smith), Emory University (M.H.C.), and Centers for Disease Control and Prevention (M. Saraiya), Atlanta, GA; Amsterdam University Medical Centers, Amsterdam, the Netherlands (J. Berkhof); Azienda Unità Sanitaria Locale, IRCCS Reggio Emilia, Reggio Emilia, Italy (P.G.-R.); Casablanca Cancer Registry, Casablanca, Morocco (K.B.); Center for the Study of the State and Society (S.A.), and National Scientific and Technical Research Council (S.A.), Buenos Aires, Argentina; Chinese Academy of Medical Sciences, Beijing, China (F.Z.); Hospital Clínic de Barcelona, Barcelona, Spain (M.d.P.); Hospital Universitario San Ignacio, Bogota, Colombia (R.M.); International Agency for Research on Cancer, Lyon (V.B., W.P., B.I.I.R., I.M.-M., B.L.-S.); Karolinska Institutet, Stockholm, Sweden (M.E.); McGill University, Montreal, Quebec, Canada (E.L.F.); National Cancer Institute, Bangkok, Thailand (S.S.); National Cancer Institute, Rockville, MD (N.W., M. Schiffman); National Public Health Agency, Saint-Maurice (F.F.H.), France; PATH, Seattle, WA (S.d.S.); Public Health England and Screening, London, United Kingdom (A.M.); Research Triangle Institute International, New Delhi, India (R. Sankaranarayanan); Teikyo University (C.H.), and National Cancer Center (C.H.), Tokyo, Japan; The Daffodil Centre, a joint venture between the Cancer Council NSW and the University of Sydney, King's Cross, New South Wales, Australia (K.C.); University of Edinburgh, Edinburgh, United Kingdom (C.S.H.); University of Toronto, Toronto, Ontario, Canada (R.K.); University of Zimbabwe College of Health Sciences, Harare, Zimbabwe (Z.M.C.); VCS Foundation, Melbourne, Victoria, Australia (J. Brotherton); and Sciensano, Brussels, Belgium (M.A.)Walter PrendivilleAmerican Cancer Society (R. Smith), Emory University (M.H.C.), and Centers for Disease Control and Prevention (M. Saraiya), Atlanta, GA; Amsterdam University Medical Centers, Amsterdam, the Netherlands (J. Berkhof); Azienda Unità Sanitaria Locale, IRCCS Reggio Emilia, Reggio Emilia, Italy (P.G.-R.); Casablanca Cancer Registry, Casablanca, Morocco (K.B.); Center for the Study of the State and Society (S.A.), and National Scientific and Technical Research Council (S.A.), Buenos Aires, Argentina; Chinese Academy of Medical Sciences, Beijing, China (F.Z.); Hospital Clínic de Barcelona, Barcelona, Spain (M.d.P.); Hospital Universitario San Ignacio, Bogota, Colombia (R.M.); International Agency for Research on Cancer, Lyon (V.B., W.P., B.I.I.R., I.M.-M., B.L.-S.); Karolinska Institutet, Stockholm, Sweden (M.E.); McGill University, Montreal, Quebec, Canada (E.L.F.); National Cancer Institute, Bangkok, Thailand (S.S.); National Cancer Institute, Rockville, MD (N.W., M. Schiffman); National Public Health Agency, Saint-Maurice (F.F.H.), France; PATH, Seattle, WA (S.d.S.); Public Health England and Screening, London, United Kingdom (A.M.); Research Triangle Institute International, New Delhi, India (R. Sankaranarayanan); Teikyo University (C.H.), and National Cancer Center (C.H.), Tokyo, Japan; The Daffodil Centre, a joint venture between the Cancer Council NSW and the University of Sydney, King's Cross, New South Wales, Australia (K.C.); University of Edinburgh, Edinburgh, United Kingdom (C.S.H.); University of Toronto, Toronto, Ontario, Canada (R.K.); University of Zimbabwe College of Health Sciences, Harare, Zimbabwe (Z.M.C.); VCS Foundation, Melbourne, Victoria, Australia (J. Brotherton); and Sciensano, Brussels, Belgium (M.A.)Blanca I. Indave RuizAmerican Cancer Society (R. Smith), Emory University (M.H.C.), and Centers for Disease Control and Prevention (M. Saraiya), Atlanta, GA; Amsterdam University Medical Centers, Amsterdam, the Netherlands (J. Berkhof); Azienda Unità Sanitaria Locale, IRCCS Reggio Emilia, Reggio Emilia, Italy (P.G.-R.); Casablanca Cancer Registry, Casablanca, Morocco (K.B.); Center for the Study of the State and Society (S.A.), and National Scientific and Technical Research Council (S.A.), Buenos Aires, Argentina; Chinese Academy of Medical Sciences, Beijing, China (F.Z.); Hospital Clínic de Barcelona, Barcelona, Spain (M.d.P.); Hospital Universitario San Ignacio, Bogota, Colombia (R.M.); International Agency for Research on Cancer, Lyon (V.B., W.P., B.I.I.R., I.M.-M., B.L.-S.); Karolinska Institutet, Stockholm, Sweden (M.E.); McGill University, Montreal, Quebec, Canada (E.L.F.); National Cancer Institute, Bangkok, Thailand (S.S.); National Cancer Institute, Rockville, MD (N.W., M. Schiffman); National Public Health Agency, Saint-Maurice (F.F.H.), France; PATH, Seattle, WA (S.d.S.); Public Health England and Screening, London, United Kingdom (A.M.); Research Triangle Institute International, New Delhi, India (R. Sankaranarayanan); Teikyo University (C.H.), and National Cancer Center (C.H.), Tokyo, Japan; The Daffodil Centre, a joint venture between the Cancer Council NSW and the University of Sydney, King's Cross, New South Wales, Australia (K.C.); University of Edinburgh, Edinburgh, United Kingdom (C.S.H.); University of Toronto, Toronto, Ontario, Canada (R.K.); University of Zimbabwe College of Health Sciences, Harare, Zimbabwe (Z.M.C.); VCS Foundation, Melbourne, Victoria, Australia (J. Brotherton); and Sciensano, Brussels, Belgium (M.A.)Isabel Mosquera-MetcalfeAmerican Cancer Society (R. Smith), Emory University (M.H.C.), and Centers for Disease Control and Prevention (M. Saraiya), Atlanta, GA; Amsterdam University Medical Centers, Amsterdam, the Netherlands (J. Berkhof); Azienda Unità Sanitaria Locale, IRCCS Reggio Emilia, Reggio Emilia, Italy (P.G.-R.); Casablanca Cancer Registry, Casablanca, Morocco (K.B.); Center for the Study of the State and Society (S.A.), and National Scientific and Technical Research Council (S.A.), Buenos Aires, Argentina; Chinese Academy of Medical Sciences, Beijing, China (F.Z.); Hospital Clínic de Barcelona, Barcelona, Spain (M.d.P.); Hospital Universitario San Ignacio, Bogota, Colombia (R.M.); International Agency for Research on Cancer, Lyon (V.B., W.P., B.I.I.R., I.M.-M., B.L.-S.); Karolinska Institutet, Stockholm, Sweden (M.E.); McGill University, Montreal, Quebec, Canada (E.L.F.); National Cancer Institute, Bangkok, Thailand (S.S.); National Cancer Institute, Rockville, MD (N.W., M. Schiffman); National Public Health Agency, Saint-Maurice (F.F.H.), France; PATH, Seattle, WA (S.d.S.); Public Health England and Screening, London, United Kingdom (A.M.); Research Triangle Institute International, New Delhi, India (R. Sankaranarayanan); Teikyo University (C.H.), and National Cancer Center (C.H.), Tokyo, Japan; The Daffodil Centre, a joint venture between the Cancer Council NSW and the University of Sydney, King's Cross, New South Wales, Australia (K.C.); University of Edinburgh, Edinburgh, United Kingdom (C.S.H.); University of Toronto, Toronto, Ontario, Canada (R.K.); University of Zimbabwe College of Health Sciences, Harare, Zimbabwe (Z.M.C.); VCS Foundation, Melbourne, Victoria, Australia (J. Brotherton); and Sciensano, Brussels, Belgium (M.A.)Béatrice Lauby-SecretanAmerican Cancer Society (R. Smith), Emory University (M.H.C.), and Centers for Disease Control and Prevention (M. Saraiya), Atlanta, GA; Amsterdam University Medical Centers, Amsterdam, the Netherlands (J. Berkhof); Azienda Unità Sanitaria Locale, IRCCS Reggio Emilia, Reggio Emilia, Italy (P.G.-R.); Casablanca Cancer Registry, Casablanca, Morocco (K.B.); Center for the Study of the State and Society (S.A.), and National Scientific and Technical Research Council (S.A.), Buenos Aires, Argentina; Chinese Academy of Medical Sciences, Beijing, China (F.Z.); Hospital Clínic de Barcelona, Barcelona, Spain (M.d.P.); Hospital Universitario San Ignacio, Bogota, Colombia (R.M.); International Agency for Research on Cancer, Lyon (V.B., W.P., B.I.I.R., I.M.-M., B.L.-S.); Karolinska Institutet, Stockholm, Sweden (M.E.); McGill University, Montreal, Quebec, Canada (E.L.F.); National Cancer Institute, Bangkok, Thailand (S.S.); National Cancer Institute, Rockville, MD (N.W., M. Schiffman); National Public Health Agency, Saint-Maurice (F.F.H.), France; PATH, Seattle, WA (S.d.S.); Public Health England and Screening, London, United Kingdom (A.M.); Research Triangle Institute International, New Delhi, India (R. Sankaranarayanan); Teikyo University (C.H.), and National Cancer Center (C.H.), Tokyo, Japan; The Daffodil Centre, a joint venture between the Cancer Council NSW and the University of Sydney, King's Cross, New South Wales, Australia (K.C.); University of Edinburgh, Edinburgh, United Kingdom (C.S.H.); University of Toronto, Toronto, Ontario, Canada (R.K.); University of Zimbabwe College of Health Sciences, Harare, Zimbabwe (Z.M.C.); VCS Foundation, Melbourne, Victoria, Australia (J. Brotherton); and Sciensano, Brussels, Belgium (M.A.)
2022en
ABI
Аннотация
(Abstracted from N Engl J Med 2021;385:1908–1918) In May 2018, the World Health Organization (WHO) called for the elimination of global cervical cancer as a major public health priority, with a 2-pronged approach focusing on effective vaccination against human papillomavirus (HPV) and the screening for and treatment of early cervical cancer. Cervical cancer is considered largely preventable through these programs; however, it continues to be disproportionately prevalent in countries with the lowest values on the Human Development Index.
Перевод пока недоступен
Идентификаторы
Цитирования и источники
Цитирований: 2Использованных источников: 0